Informations générales (source: ClinicalTrials.gov)
Identification of Reversible Cerebral Vasoconstriction Syndrome's Precipitating Factors. Triggers And Risk Factors to Develop a Reversible Cerebral Vasoconstriction Syndrome (TARDIS)
Interventional
N/A
University Hospital, Montpellier (Voir sur ClinicalTrials)
décembre 2019
septembre 2024
29 juin 2024
This study will be the first to evaluate the role played by potential precipitating
factors and risk factors in Reversible Cerebral Vasoconstriction Syndrome (RCVS) through
of prospective selection of carefully characterised patients and controls. The impact of
these factors on the prognosis will be evaluated through a follow-up assessment of
patients.
Our study will include the formation of a clinicoradiological database and a biobank
(plasma, cerebro-spinal fluid, DNA) which will be the tools of a future large multicentre
study on RCVS.
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Gui de Chauliac Hospital - 34295 - Montpellier - France | Lucas CORTI | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion criteria:
- For the Patients
- Men and women of 18 and more years old
- Taken care in the CHU of Montpellier
- Diagnosis of SVCR or SVCR without visible vasoconstriction makes in 14 days
preceding the inclusion
- According to the consensual criteria of diagnosis and those of the
international classification of the headaches ICHD-3
- Informed consent and writes for the participation in the study
- For volunteers
- Men and women of 18 and more, mated in the Cases on the sex and the age
- Patients with an acute pathology not Neurological and not vascular (for
example, eye foreign body) OR Healthy Subjects
- Informed written consent and for the participation in the study
- For the Patients
- Men and women of 18 and more years old
- Taken care in the CHU of Montpellier
- Diagnosis of SVCR or SVCR without visible vasoconstriction makes in 14 days
preceding the inclusion
- According to the consensual criteria of diagnosis and those of the
international classification of the headaches ICHD-3
- Informed consent and writes for the participation in the study
- For volunteers
- Men and women of 18 and more, mated in the Cases on the sex and the age
- Patients with an acute pathology not Neurological and not vascular (for
example, eye foreign body) OR Healthy Subjects
- Informed written consent and for the participation in the study
- Coma, insanity, language barrier or severe aphasia preventing from answering the
questions
- Follow-up considered impossible for 3 months (e.g.: priority associated pathology in
the care, the transfer(transformation))
- People placed under legal protection
- Refusal to participate in the study